QA: Merus N V in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001651311_2023_Merus_N_V.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Large missing amount for aggregate "Revenues" added to remainder. industry.us_generic {'missing_ratio': inf, 'aggregate_val': 41586000, 'exp_sum': 0, 'exp_to_value': {'remainder_Revenues': 0}}

Graph

Absolute values for 0001651311, Merus N V

  xvar xval
0 AssetsCurrent 306,443,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 12,222,000
3 remainder_Assets 57,877,000
4 LiabilitiesCurrent 78,926,000
5 LiabilitiesNoncurrent 11,790,000
6 remainder_Liabilities 38,771,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 53,504,460
9 ResearchAndDevelopmentExpense 232,278,600
10 remainder_Expenses 242,279
11 remainder_Revenues 43,112,882
12 remainder_NetIncome 29,341,101
13 remainder_ComprehensiveNetIncome -20,700,307
  yvar yval
0 Assets 376,542,000
1 Liabilities 129,487,000
2 Expenses 286,025,339
3 Revenues 43,112,882
4 StockholdersEquity 247,055,000
5 NetIncome -213,571,356
6 ComprehensiveNetIncome -223,921,510
7 BaseVar 442,604,314
8 EconomicCapitalRatiobeforeLimitedLiability 1.24
9 EconomicCapitalRatio 2.49

Edgar->Model Mapping

Feature Distribution

Change over Time